PINTO, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 323
EU - Europa 163
AS - Asia 47
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 535
Nazione #
US - Stati Uniti d'America 320
GB - Regno Unito 46
DE - Germania 41
SE - Svezia 32
IT - Italia 16
HK - Hong Kong 15
SG - Singapore 12
CN - Cina 10
BG - Bulgaria 4
FR - Francia 4
IN - India 4
RU - Federazione Russa 4
ID - Indonesia 3
LT - Lituania 3
UA - Ucraina 3
BE - Belgio 2
CA - Canada 2
FI - Finlandia 2
IE - Irlanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BR - Brasile 1
CZ - Repubblica Ceca 1
ES - Italia 1
IR - Iran 1
MY - Malesia 1
NL - Olanda 1
NO - Norvegia 1
PA - Panama 1
TR - Turchia 1
Totale 535
Città #
Fairfield 45
Chandler 42
Southend 34
Ashburn 30
Houston 28
Nyköping 24
Woodbridge 24
Ann Arbor 18
Cambridge 16
Hong Kong 14
Wilmington 14
Seattle 11
Frankfurt am Main 8
New York 8
Singapore 7
San Diego 6
Bremen 5
Fremont 5
Jacksonville 5
Princeton 4
Sofia 4
Dearborn 3
Jakarta 3
Philadelphia 3
Beijing 2
Boardman 2
Brussels 2
Dublin 2
Eugene 2
Guntur 2
Helsinki 2
London 2
Albuquerque 1
Amsterdam 1
As 1
Bangalore 1
Battipaglia 1
Berlin 1
Brno 1
Central 1
Chiswick 1
Frattamaggiore 1
Giugliano in Campania 1
Guangzhou 1
Hounslow 1
Izmir 1
Kilburn 1
Kuala Lumpur 1
Los Angeles 1
Madrid 1
Modena 1
Montegaldella 1
Nanjing 1
Nanning 1
Ottawa 1
Panama City 1
Paris 1
Perugia 1
Prescot 1
Redwood City 1
San Jose 1
San Mateo 1
Shanghai 1
Stanford 1
Toronto 1
Zanjan 1
Zocca 1
Totale 412
Nome #
Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program 253
Identification of a 2,4-diaminopyrimidine scaffold targeting Trypanosoma brucei pteridine reductase 1 from the LIBRA compound library screening campaign 127
Characterization of 2,4-Diamino-6-oxo-1,6-dihydropyrimidin-5-yl Ureido Based Inhibitors of Trypanosoma brucei FolD and Testing for Antiparasitic Activity 83
COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies 51
Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV 27
Totale 541
Categoria #
all - tutte 3.053
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.053


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202055 0 2 1 6 4 8 11 6 7 3 4 3
2020/2021120 7 2 35 9 4 12 1 13 4 22 6 5
2021/202283 9 12 2 3 2 11 4 2 8 6 13 11
2022/2023129 15 15 10 15 19 12 3 12 15 0 6 7
2023/202476 2 3 5 5 18 6 10 10 0 1 7 9
2024/202513 12 1 0 0 0 0 0 0 0 0 0 0
Totale 541